Engineers India Ltd (ENGINERSIN) Q1 FY27 Results Analysis: PAT Surges 141.5%, Record Order Book Rs. 15,109 Cr
Engineers India Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 819.84 Cr (-5.80% YoY) and PAT growth of +141.49% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 13, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 819.84 Cr (-5.80% YoY) |
| PAT (Q1) | Rs. 157.94 Cr (+141.49% YoY) |
| EBITDA margin | 24.14% (+1299 bps YoY) |
| EPS (Q1) | Rs. 2.81 (+142.24% YoY) |
| Market cap | Rs. 13,521.62 Cr |
| CMP | Rs. 240.58 |
Quarter Snapshot
Revenue fell 5.8% YoY but PAT surged 141.5% as consultancy margins recovered sharply and JV profitability swung to a Rs.42.5 Cr profit. The record order book of Rs.15,109 Cr provides pipeline visibility, but the revenue trajectory needs to accelerate to meet the FY27 Rs.4,000 Cr target. Execution on turnkey and continued mix shift toward consultancy will be key.
Key Investment Insights
Key Positives
- Consolidated PAT surged 141.5% YoY to Rs.157.94 Cr, driven by consultancy margin recovery and JV turnaround
- Consultancy & Engineering segment revenue grew 22.9% YoY; segment margin improved from 16.93% to 24.85%
- JV share turned from loss of Rs.7.37 Cr to profit of Rs.42.51 Cr, a swing of Rs.49.88 Cr
- Order book of Rs.15,109 Cr provides strong revenue visibility for coming quarters
- EBITDA margin expanded 1,299 bps YoY to 24.14% on total income
Risk Factors
- Consolidated revenue declined 5.8% YoY to Rs.819.84 Cr, missing the trajectory needed for FY27 revenue target of Rs.4,000 Cr
- Turnkey Projects revenue fell 32.8% YoY due to lumpy execution, though margins improved
- Employee benefit expenses as % of revenue rose 374 bps to 32.32%, partly due to lower revenue base
- Board composition non-compliance flagged in FY26 audit remains unaddressed in this quarter
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.